CETPARP

CETPARP (Centre d'Etude et de Traitement de la Pathologie de l'Appareil Reproducteur et de la Psychosomatique) is a specialized research center and clinic based in Lille, France, focused on sexual and reproductive health. Led by the prominent andrologist Dr. Jacques Buvat, the center is a key site for clinical trials and academic research in the fields of andrology and sexual medicine. It has been involved in significant studies for major pharmaceutical products, including PDE5 inhibitors like tadalafil and vardenafil, as well as various testosterone replacement therapies. The center's work encompasses the diagnosis and treatment of erectile dysfunction, premature ejaculation, and male hypogonadism, often collaborating with global pharmaceutical companies as a non-commercial sponsor or clinical site.